Clovis Oncology: The Best-Performing Biotechs of 2013
Here's why Clovis Oncology Inc. (CLVS) has posted a gain of over 200% this year.
5 Stocks With Triple-Digit P/Es That This Value Investor Would Consider Buying
Even if you're a staunch value investor, check out these five stocks for their incredible growth potential.
Stock Upgrades: Ain't No Mountain High Enough for Vail Resorts
Wall street ratings agencies set the tone for today's stock market.